2-(4-BROMOPHENYL)-5-(1-NAPHTHYL)-1,3,4-OXADIAZOLE
UNII 3FS9B9SGX8
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-(4-bromophenyl)-5-(1-naphthyl)-1,3,4-oxadiazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3FS9B9SGX8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 68047-37-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H11BrN2O VZEIYIPOCFGTPV-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-(4-bromophenyl)-5-(1-naphthyl)-1,3,4-oxadiazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.